In focus
Latest feed
India Plots a Fresh Push to Strengthen Bulk‑Drug R&D Capacity
Gujarat Themis Biosyn's Rs 1,300 Crore Coup: A Strategic Leap into Global API Dominance
The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth
India's Pharmaceutical Renaissance: How the PLI Scheme is Forging Self-Reliance in API Manufacturing
